Press

2019    2018    2017    2016    2015    2014    2013    2012    

Nephros Announces Listing on Nasdaq Capital Market

By nephros, In , On August 13, 2019

SOUTH ORANGE, NJ, August 13, 2019 – Nephros, Inc. (OTCQB: NEPH), a commercial-stage company that develops and sells high performance…

Download PDF »

Nephros Reports Second Quarter Financial Results

By nephros, In , On August 07, 2019

SOUTH ORANGE, NJ, August 7, 2019 – Nephros, Inc. (OTCQB:NEPH), a commercial stage company that develops and sells high performance water purification products to the medical device and commercial markets,…

Download PDF »

Nephros Announces Second Quarter 2019 Financial Results Conference Call and Record Revenue of Over $1 Million in July

By nephros, In , On July 30, 2019

SOUTH ORANGE, NJ, July 30, 2019 – Nephros, Inc. (OTCQB: NEPH), a commercial-stage company that develops and sells high performance water purification products to the medical device and commercial markets,…

Download PDF »

Nephros Announces Temporary Ticker Symbol Following Reverse Stock Split

By nephros, In , On July 10, 2019

Common Stock Will Trade Under Ticker “NEPHD” For 20 Trading Days SOUTH ORANGE, NJ, July 10, 2019 – Nephros, Inc. (OTCQB: NEPHD), a commercial-stage company that develops and sells high…

Download PDF »

Nephros Announces Preliminary Financial Results for Second Quarter 2019 and Reverse Stock Split

By nephros, In , On July 09, 2019

Anticipates $2.3 Million Net Revenue; 70% Growth Over Prior Year Reiterates Full-Year 2019 Revenue Guidance SOUTH ORANGE, NJ, July 9, 2019 – Nephros, Inc. (OTCQB: NEPH), a commercial-stage company that…

Download PDF »

Nephros Announces $2 Million Private Placement

By nephros, In , On May 16, 2019

SOUTH ORANGE, NJ, May 16, 2019 – Nephros, Inc. (OTCQB:NEPH) (the “Company”), a commercial stage company that develops and sells high performance water purification products to the medical device and…

Download PDF »

Nephros Reports First Quarter Financial Results

By nephros, In , On May 08, 2019

Revenues up 80% over Q1 2018 Driven by Hospital Footprint Expansion Reiterates 2019 Guidance for Revenue Growth of 50% to 65% SOUTH ORANGE, NJ, May 8, 2019 – Nephros, Inc.…

Download PDF »

Nephros Appoints Tom Gwydir to its Board of Directors

By nephros, In , On May 01, 2019

SOUTH ORANGE, NJ, May 1, 2019 – Nephros, Inc. (OTCQB: NEPH), a commercial stage company that develops and sells high-performance water purification products to the medical device and commercial markets,…

Nephros to Report First Quarter 2019 Financial Results on May 8, 2019

By nephros, In , On May 01, 2019

SOUTH ORANGE, NJ, May 1, 2019 – Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, today announced that it…

Nephros To Present at Taglich Brothers 16th Annual Investment Conference on April 30, 2019 in New York City

By nephros, In , On April 24, 2019

SOUTH ORANGE, NJ, April 24, 2019 – Nephros, Inc. (OTCQB:NEPH), a commercial stage company that develops and sells high performance liquid purification filters for both medical device and commercial markets,…

Download PDF »

Nephros Announces Preliminary Financial Results for First Quarter 2019 Anticipates $1.7 Million Revenue; Year-over-Year Growth Exceeds 75%

By nephros, In , On April 08, 2019

SOUTH ORANGE, NJ, April 8, 2019 – Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device and commercial products company that develops and sells high performance water purification products, today…

Nephros To Present at the Spring Investor Summit on April 1st in New York City

By nephros, In , On March 29, 2019

SOUTH ORANGE, NJ, March 29, 2019 /PR Newswire-FirstCall/ – Nephros, Inc. (OTCQB:NEPH), a commercial stage company that develops and sells high performance liquid purification filters for both medical device and…

Nephros Reports 2018 Fourth Quarter and Full Year Financial Results and Provides Corporate Update Annual Product Revenues Up 54%

By nephros, In , On March 12, 2019

Nephros Reports 2018 Fourth Quarter and Full Year Financial Results and Provides Corporate Update Annual Product Revenues Up 54% SOUTH ORANGE, NJ, March 12, 2019 – Nephros, Inc. (OTCQB:NEPH), a…

Nephros to Present at the 2019 LD Micro Virtual Conference

By nephros, In , On March 07, 2019

LOS ANGELES, CA / ACCESSWIRE / March 7, 2019 / Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, today announced that…

Nephros to Report Fourth Quarter and Year-End 2018 Financial Results on March 12, 2019

By nephros, In , On March 06, 2019

SOUTH ORANGE, NJ, March 6, 2019 – Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, today announced that it…

Nephros Appoints Alisa Lask to its Board of Directors

By nephros, In , On February 11, 2019

SOUTH ORANGE, NJ, February 11, 2019 – Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, today announced the appointment…

Nephros Announces Preliminary Financial Results for Fiscal Year 2018

By nephros, In , On January 09, 2019

Anticipates $5.6-5.7 Million Total Revenue; Product Revenue Growth Over 50% SOUTH ORANGE, NJ, January 9, 2018 – Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and…

Nephros Announces Acquisition of Biocon

By nephros, In , On January 02, 2019

Adds Growing Water Filtration Business in Food Service, Hospitality, and Industrial Markets Expands Water Filter Product Portfolio SOUTH ORANGE, NJ, January 2, 2019 – Nephros, Inc. (OTCQB: NEPH) (“Nephros”), a…

Nephros to Present at the 11th Annual LD Micro Main Event

By nephros, In , On December 03, 2018

Presentation Scheduled for 9:30 AM PT on Tuesday, December 4th SOUTH ORANGE, NJ, Dec. 03, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Nephros, Inc. (NEPH) (“Nephros”), a commercial stage medical…

Nephros Reports Third Quarter 2018 Financial Results

By nephros, In , On November 08, 2018

Quarterly Product Revenue Up 96% Year-over-Year; Total Revenue Up 88% SOUTH ORANGE, N.J., Nov. 08, 2018 - Nephros, Inc. (NEPH) (“Nephros”), a commercial stage medical device company that develops and…

Nephros to Report Third Quarter 2018 Financial Results on November 8th, 2018

By nephros, In , On November 01, 2018

SOUTH ORANGE, NJ, November 1, 2018 – Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, today announced that it…

Nephros Announces Preliminary Financial Results for Third Quarter 2018

By nephros, In , On October 01, 2018

Anticipates 102% Year-over-Year Product Revenue Growth; Reiterates $6 Million 2018 Revenue Target SOUTH ORANGE, NJ, Oct. 01, 2018 -- Nephros, Inc. (NEPH), a commercial stage medical device company that develops…

Specialty Renal Products Announces $3 Million Series A Financing

By nephros, In , On September 06, 2018

SOUTH ORANGE, NJ, September 6, 2018 – Specialty Renal Products, Inc. (SRP), a private medical device company focused on the development of products for patients with renal disease, including a…

Nephros Subsidiary Specialty Renal Products and HemoCleanse Announce License Agreement for Dialysate Filtration System

By nephros, In , On August 14, 2018

Pioneering HemoCleanse CEO to Join Specialty Renal Products Board of Directors SOUTH ORANGE, NJ, August 14, 2018 – Specialty Renal Products, Inc. (SRP), a subsidiary of Nephros, Inc. (OTCQB:NEPH), a…

Nephros Appoints Oliver Spandow to its Board of Directors

By nephros, In , On August 13, 2018

Seasoned Executive Adds Significant Operational and M&A Expertise SOUTH ORANGE, NJ, August 13, 2018 -- Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high…

Nephros Reports Second Quarter 2018 Financial Results

By nephros, In , On August 08, 2018

Total Revenue Up 59% Year-over-Year Company Plans Uplist to National Stock Exchange Conference Call Scheduled Today, August 8, at 4:30PM EDT SOUTH ORANGE, NJ, August 8, 2018 – Nephros, Inc. (OTCQB:…

Nephros Schedules Second Quarter Financial Results Conference Call

By nephros, In , On August 03, 2018

Call scheduled for Wednesday, August 8th at 4:30 PM EDT August 3, 2018 – Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance…

Nephros Announces Preliminary Financial Results for Second Quarter 2018

By nephros, In , On July 09, 2018

Anticipates 57% Year-over-Year Revenue Growth; Establishes Specialty Renal Products Subsidiary SOUTH ORANGE, NJ, July 9, 2018 /PR Newswire-FirstCall/ – Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that…

Nephros to Present at 8th Annual LD Micro Invitational

By nephros, In , On June 04, 2018

Nephros to Present at 8th Annual LD Micro Invitational SOUTH ORANGE, NJ, June 4, 2018 /PR Newswire-FirstCall/ – Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells…

Medical Device Company Nephros, Inc. Credits State’s NOL Program with Fueling Growth

By nephros, In , On May 10, 2018

TRENTON, N.J. (May 10, 2018) – With support from the New Jersey Economic Development Authority (EDA), medical device maker Nephros, Inc. has developed and commercialized water-filtration systems designed to decrease…

Nephros Reports First Quarter 2018 Financial Results

By nephros, In , On May 09, 2018

Nephros Reports First Quarter 2018 Financial Results Quarterly Product Revenue Up 39% Year-over-Year; Reiterates Full-Year Revenue Guidance of $6 Million SOUTH ORANGE, NJ, May 9, 2018 /PR Newswire-FirstCall/ -- Nephros,…

Nephros Announces Preliminary Financial Results for First Quarter 2018

By nephros, In , On April 16, 2018

Anticipates 39% Year-over-Year Product Revenue Growth; Reiterates $6 Million 2018 Revenue Target SOUTH ORANGE, NJ, April 16, 2018 /PR Newswire-FirstCall/ – Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device…

Nephros Announces $2.9 Million Private Placement

By nephros, In , On April 11, 2018

SOUTH ORANGE, NJ, April 11, 2018 /PR Newswire-FirstCall/ – Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line…

Nephros Reports 2017 Fourth Quarter and Full Year Financial Results and Provides Corporate Update

By nephros, In , On February 26, 2018

Nephros Reports 2017 Fourth Quarter and Full Year Financial Results and Provides Corporate Update Annual Revenues Up 65% and Cash Flow from Operations Approaches Breakeven SOUTH ORANGE, NJ, February 26,…

Nephros to Present at NobleCon14

By nephros, In , On January 23, 2018

Nephros to Present at NobleCon14 SOUTH ORANGE, NJ, January 23, 2018 /PR Newswire-FirstCall/ - Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid…

Nephros Announces Preliminary Financial Results for Fourth Quarter 2017

By nephros, In , On January 04, 2018

Nephros Announces Preliminary Financial Results for Fourth Quarter 2017 Anticipates Over 80% Year-over-Year Product Revenue Growth for the Quarter SOUTH ORANGE, NJ, January 4, 2018 /PR Newswire-FirstCall/ – Nephros, Inc.…

Nephros Receives $1.8 Million in Cash from Sale of Tax Credits

By nephros, In , On December 13, 2017

Nephros Receives $1.8 Million in Cash from Sale of Tax Credits SOUTH ORANGE, NJ, December 13, 2017 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTCQB: NEPH) a commercial stage medical device company that…

Nephros CFO to Present at the 10th Annual LD Micro Main Event

By nephros, In , On December 04, 2017

Nephros CFO to Present at the 10th Annual LD Micro Main Event LOS ANGELES, CA / ACCESSWIRE / December 4, 2017 / Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company…

Nephros Reports Third Quarter 2017 Financial Results

By nephros, In , On November 09, 2017

Nephros Reports Third Quarter 2017 Financial Results Quarterly Revenue Up 93% Year-over-Year RIVER EDGE, NJ, November 9, 2017 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTCQB: NEPH) (the “Company”), a commercial stage…

Nephros Announces Approval of $1.9 Million in NJEDA NOL Program Tax Credits

By nephros, In , On November 06, 2017

Nephros Announces Approval of $1.9 Million in NJEDA NOL Program Tax Credits Non-Dilutive Net Proceeds of Over $1.75 Million Expected in Late Q4 2017 RIVER EDGE, NJ, November 6, 2017…

Nephros Provides Corporate Update and Announces Preliminary Third Quarter 2017 Revenue

By nephros, In , On October 16, 2017

Nephros Provides Corporate Update and Announces Preliminary Third Quarter 2017 Revenue Anticipates Over 90% Year-over-Year Revenue Growth in the Third Quarter and Cash Flow Breakeven around Year-End RIVER EDGE, NJ,…

Nephros Shareholder Letter – 9/27/2017

By nephros, In , On September 27, 2017

Dear Friends and Shareholders, This is an exciting time for Nephros. Demand for our products is increasing, revenue and growth rates are expanding, and we anticipate continued progress. At the…

Nephros Reports Second Quarter Financial Results and Receives NJEDA Approval for Approximately $1.5 million in Funding from Sale of Tax Credits

By nephros, In , On August 08, 2017

Nephros Reports Second Quarter Financial Results and Receives NJEDA Approval for Approximately $1.5 million in Funding from Sale of Tax Credits Revenue Increases 69% Year-over-Year RIVER EDGE, NJ, August 8,…

Nephros to Present at Marcum 2017 MicroCap Conference

By nephros, In , On June 09, 2017

Nephros to Present at Marcum 2017 MicroCap Conference Presentation on Thursday June 15, 2017 at 4:00pm ET RIVER EDGE, NJ, June 9, 2017 -- Nephros, Inc. (OTCQB:NEPH) (the “Company”), a…

Nephros Reports 2017 First Quarter Financial Results and Provides Corporate Update

By nephros, In , On May 09, 2017

Nephros Reports 2017 First Quarter Financial Results and Provides Corporate Update RIVER EDGE, NJ, May 9, 2017 /Marketwired/ -- Nephros, Inc. (OTCQB: NEPH) (the “Company”), a commercial stage medical device…

Nephros Announces Partnership with WorldWater & Solar Technologies

By nephros, In , On April 24, 2017

Nephros Announces Partnership with WorldWater & Solar Technologies  RIVER EDGE, NJ, April 24, 2017 /Issuer Direct / Nephros, Inc. (OTCQB:NEPH), (the “Company”) a commercial stage medical device company that develops…

Nephros Reports 2016 Fourth Quarter and Full Year Financial Results and Provides Corporate Update

By nephros, In , On March 20, 2017

Nephros Reports 2016 Fourth Quarter and Full Year Financial Results and Provides Corporate Update  Anticipates 100% Year Over Year Growth in Medical Device Filters; Anticipates Reaching Cash Flow Positive in…

Nephros Announces $1.2 Million Private Placement

By nephros, In , On March 17, 2017

Nephros Announces $1.2 Million Private Placement RIVER EDGE, NJ--(Marketwired - Mar 17, 2017) - Nephros, Inc. ( OTCQB : NEPH ) (the "Company"), a commercial stage medical device company that develops and sells high…

Nephros Receives FDA 510(k) Clearance of EndoPur Endotoxin 10” Filter

By nephros, In , On March 06, 2017

Nephros Receives FDA 510(k) Clearance of EndoPurTM Endotoxin 10” Filter Launch Expected in Second Quarter of 2017 RIVER EDGE, NJ, March 6, 2017 /MarketWired/ -- Nephros, Inc. (OTCQB:NEPH) (the “Company”),…

Nephros Announces Appointment of Andrew Astor as Chief Financial Officer

By nephros, In , On February 14, 2017

Nephros Announces Appointment of Andrew Astor as Chief Financial Officer Technology Industry Veteran Andrew Astor Hired to Support Growth and Business Momentum RIVER EDGE, NJ, February 14, 2017 /Market Wire/…

Nephros Provides Corporate Update and Fourth Quarter 2016 Revenue Guidance

By nephros, In , On January 24, 2017

Nephros Provides Corporate Update and Fourth Quarter 2016 Revenue Guidance --Projects Positive Cash Flow by Mid 2017-- RIVER EDGE, NJ, January 24, 2017 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTCQB:NEPH) (the…

Nephros Receives FDA 510(k) Clearance of HydraGuard 10” UltraFilter

By nephros, In , On December 27, 2016

Nephros Receives FDA 510(k) Clearance of HydraGuardTM 10” UltraFilter Expands Hospital Infection Control Product Line RIVER EDGE, NJ, December 27, 2016 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTCQB:NEPH) (the “Company”), a…

Nephros Provides Corporate Update and Third Quarter 2016 Revenue Guidance

By nephros, In , On October 11, 2016

Nephros Provides Corporate Update and Third Quarter 2016 Revenue Guidance RIVER EDGE, NJ, October 11, 2016 /Issuer Direct/ -- Nephros, Inc. (OTCQB:NEPH) (the “Company”), a commercial stage medical device company…

Nephros Announces Participation at the 18th Annual Rodman & Renshaw Global Investment Conference

By nephros, In , On August 29, 2016

RIVER EDGE, NJ, August 29, 2016 /Issuer Direct -- Nephros, Inc. (OTCQB:NEPH) (the “Company”), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and…

Nephros Announces Agreement to Initiate HDF Treatment at Vanderbilt Dialysis Clinic

By nephros, In , On August 25, 2016

RIVER EDGE, NJ, August 25, 2016 /Issuer Direct/ -- Nephros, Inc. (OTCQB:NEPH) (the “Company”), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and…

Nephros Reports Second Quarter 2016 Financial Results

By nephros, In , On August 08, 2016

RIVER EDGE, NJ, August 08, 2016 -- Nephros, Inc. (OTCQB: NEPH), (the “Company”) a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an…

Nephros Announces Closing of $1.2 Million Note and Warrant Offering

By nephros, In , On June 09, 2016

RIVER EDGE, NJ, June 9, 2016 /Issuer’s Direct/ -- Nephros, Inc. (OTCQB:NEPH) (the “Company”), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and…

Nephros, Inc. Announces Distribution Agreement with CS Medical, LLC

By nephros, In , On May 23, 2016

RIVER EDGE, NJ, May 23 , 2016 /Issuer Direct / -- Nephros, Inc. (OTCQB:NEPH), (the “Company”) a commercial stage medical device company that develops and sells high performance liquid purification…

Nephros Reports First Quarter 2016 Financial Results

By nephros, In , On May 11, 2016

RIVER EDGE, NJ, May 11, 2016 -- Nephros, Inc. (OTCQB: NEPH), (the “Company”) a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an…

Nephros Announces Submission of Special 510(k) Application to the FDA for the EndoPurTM Ultrafilter

By nephros, In , On April 21, 2016

RIVER EDGE, NJ, April 21, 2016 /Issuer Direct / -- Nephros, Inc. (OTCQB:NEPH), (the “Company”) a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters…

Nephros Receives FDA 510(k) Clearance of S100 Point of Use Filter

By nephros, In , On April 14, 2016

RIVER EDGE, NJ, April 14, 2016-- Nephros, Inc. (OTCQB:NEPH), (the “Company”) a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution…

Nephros Reports 2015 Fourth Quarter and Full Year Financial Results; Provides 2016 Guidance and Potential Upcoming Milestones

By nephros, In , On March 30, 2016

Reports 90% Annual Ultrafilter Product Sales Growth— --Pending FDA clearance, Aims to launch the S100 Point of Use microfilter in 2Q’16 and the EndoPurTM Endotoxin Filter Cartridge near the end…

Nephros Launches SSUmini and Provides S100 Update

By nephros, In , On March 16, 2016

Nephros Launches SSUmini and Provides S100 Update RIVER EDGE, NJ, March 16, 2016 /Businesswire/ -- Nephros, Inc. (OTCQB:NEPH) (the “Company”), a commercial stage medical device company that develops and sells…

Nephros Reports Preliminary 2015 Revenue and Provides Update

By nephros, In , On February 01, 2016

RIVER EDGE, NJ, February 1, 2016 /Businesswire/ -- Nephros, Inc. (OTCQB:NEPH) (the “Company”), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an…

Nephros Announces  Publication of Observational Trial of DSU-D in a Hospital-Based Dialysis Facility

By nephros, In , On January 18, 2016

RIVER EDGE, NJ, January 18, 2016 /Businesswire / -- Nephros, Inc. (OTCQB:NEPH),(the “Company”) a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an…

Nephros Announces Retirement of Chairman

By nephros, In , On December 30, 2015

RIVER EDGE, NJ, December 30, 2015 /Businesswire / -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line…

Nephros, Inc. Completes Warrant Exercise Offer

By nephros, In , On December 21, 2015

River Edge, NJ, December 21, 2015/Businesswire/ -- Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution…

Nephros, Inc. Announces Offer to Exercise 2011 Warrants

By nephros, In , On November 20, 2015

River Edge, NJ, November 20, 2015 /Businesswire/ -- Nephros, Inc. (OTCQB: NEPH), acommercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution…

Nephros Announces Strategic Collaboration with Biocon 1, LLC

By nephros, In , On November 18, 2015

RIVER EDGE, NJ, November 18, 2015 /Businesswire/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution…

Nephros Reports 2015 Third Quarter Financial Results

By nephros, In , On November 10, 2015

Nephros Reports 2015 Third Quarter Financial Results RIVER EDGE, NJ, November 10, 2015 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high…

Nephros Announces FDA 510(k) Submission of S100 Ultrafilter

By nephros, In , On October 27, 2015

RIVER EDGE, NJ, October 27, 2015 /Businesswire/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution…

Nephros Announces Upcoming Poster Presentation at the American Society of Nephrology’s Kidney Week 2015

By nephros, In , On October 22, 2015

RIVER EDGE, NJ, October 22, 2015 /Businesswire/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution…

Nephros Announces Funding from Warrant Exercise by Wexford Capital and Plan to Temporarily Reduce Exercise Price for All Outstanding Warrants

By nephros, In , On September 30, 2015

RIVER EDGE, NJ, September 30, 2015 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line…

Download PDF »

Nephros to Present at Upcoming Investor Conferences

By nephros, In , On September 29, 2015

RIVER EDGE, NJ, September 29, 2015 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line…

Nephros Introduces the “Nephros Challenge” Campaign

By nephros, In , On September 21, 2015

RIVER EDGE, NJ, September 21, 2015 /Businesswire/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution…

Nephros Appoints Moshe Pinto to its Board of Directors

By nephros, In , On August 17, 2015

Nephros Appoints Moshe Pinto to its Board of Directors RIVER EDGE, NJ, August 17, 2015 /Businesswire/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells…

Nephros Reports 2015 Second Quarter Financial Results

By nephros, In , On August 10, 2015

RIVER EDGE, NJ, August 10, 2015 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line…

Nephros, Inc. Enters Into Purchase Agreement with Lincoln Park Capital Fund, LLC

By nephros, In , On July 27, 2015

RIVER EDGE, N.J., July 27, 2015 – Nephros, Inc. (OTCBB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution…

Nephros Announces the Closing of its $1.2M Private Placement

By nephros, In , On May 19, 2015

RIVER EDGE, NJ, May 19, 2015 /Businesswire/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution…

Nephros Reports 2015 First Quarter Financial Results

By nephros, In , On May 14, 2015

RIVER EDGE, NJ, May 19, 2015 /Businesswire/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution…

Nephros Announces $1.2M Private Placement

By nephros, In , On May 12, 2015

RIVER EDGE, NJ, May 12, 2015 /Businesswire/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution…

Nephros Appoints Malcolm Persen to Board of Directors

By nephros, In , On May 08, 2015

RIVER EDGE, NJ, May 8, 2015 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line…

Nephros Licenses HydraGuard Military Filter to CamelBak®

By nephros, In , On May 06, 2015

RIVER EDGE, NJ, May 6, 2015 /Businesswire/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution…

Nephros to Present at Upcoming Investor Conferences

By nephros, In , On April 22, 2015

RIVER EDGE, N.J.--(BUSINESS WIRE) January 7, 2015 -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution…

Nephros Announces Successful Completion of $3 million Rights Offering

By nephros, In , On December 18, 2014

RIVER EDGE, NJ, December 18, 2014 -- Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution…

Nephros Receives 510(k) Clearance for DSU-H and SSU-H Ultrafilters

By nephros, In , On October 28, 2014

RIVER EDGE, NJ, October 28, 2014 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line…

Nephros Completes Bridge Financing

By nephros, In , On September 03, 2014

RIVER EDGE, NJ, September 3, 2014 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line…

Nephros Reports Second Quarter 2014 Financial Results

By nephros, In , On August 14, 2015

RIVER EDGE, NJ, August 14, 2014 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line…

Nephros Announces FDA 510(k) Submission of DSU-H and SSU-H Ultrafilters to be used to filter EPA quality drinking water to remove microbiological contaminants and waterborne pathogens

By nephros, In , On June 30, 2014

RIVER EDGE, NJ, June 30, 2014 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line…

Nephros Appoints Matthew S. Rosenberg to Board of Directors

By nephros, In , On May 19, 2014

RIVER EDGE, NJ, May 19, 2014 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line…

Nephros to Present at the Third Annual Marcum MicroCap Conference

By nephros, In , On May 14, 2014

RIVER EDGE, NJ, May 14, 2014 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line…

Nephros Reports First Quarter 2014 Financial Results

By nephros, In , On May 14, 2014

RIVER EDGE, NJ, May 14, 2014 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line…

Nephros Announces First Commercial Placement of its FDA-Cleared On-line Mid-dilution Hemodiafiltration System in the United States

By nephros, In , On May 13, 2014

RIVER EDGE, NJ, May 13, 2014 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line…

Nephros Reports 2013 Fourth Quarter and Full Year Financial Results

By nephros, In , On March 28, 2014

RIVER EDGE, NJ, March 28, 2014 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line…

Nephros Announces Completion of Rights Offering

By nephros, In , On March 24, 2014

RIVER EDGE, NJ, March 24, 2014 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line…

Nephros and Mar Cor Purification Announce Distribution Agreement

By nephros, In , On March 11, 2014

RIVER EDGE, NJ, March 11, 2014 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and Mar Cor…

Nephros Provides Corporate Update

By nephros, In , On March 11, 2014

RIVER EDGE, NJ, March 11, 2014 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and a Hemodiafiltration…

Nephros Announces Rights Offering

By nephros, In , On February 12, 2014

Click Here to view External Links

Nephros Reports Second Quarter 2013 Financial Results

By nephros, In , On August 13, 2013

RIVER EDGE, NJ, August 13, 2013 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTC Bulletin Board:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced…

Nephros Reports Third Quarter 2013 Financial Results and Completes Bridge Financing

By nephros, In , On November 14, 2013

RIVER EDGE, NJ, November 14, 2013 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTC Bulletin Board:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced…

Nephros Appoints Daron Evans to Board of Directors

By nephros, In , On November 29, 2013

RIVER EDGE, NJ, November 29, 2013 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTC Bulletin Board: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters,…

Nephros Announces Completion of Rights Offering

By nephros, In , On May 23, 2013

RIVER EDGE, NJ, May 23, 2013 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTC Bulletin Board:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced…

Nephros Reports First Quarter 2013 Financial Results

By nephros, In , On May 08, 2013

RIVER EDGE, NJ, May 8, 2013 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTC Bulletin Board:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced…

Nephros Reports 2012 Fourth Quarter and Full Year Financial Results

By nephros, In , On March 04, 2013

RIVER EDGE, NJ, March 4, 2013 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTC Bulletin Board:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced…

Nephros and Chem-Aqua Announce Distribution Agreement

By nephros, In , On February 04, 2013

RIVER EDGE, NJ, February 4, 2013 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTC Bulletin Board:NEPH) and Chem-Aqua, Inc., a wholly owned water treatment subsidiary of NCH Corporation, announced today that the…

Nephros Completes Bridge Financing

By nephros, In , On February 04, 2013

RIVER EDGE, NJ, February 4, 2013 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTC Bulletin Board:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, today…

Nephros Receives €600,000 Payment from Bellco S.r.l.

By nephros, In , On January 15, 2013

RIVER EDGE, NJ, January 15, 2013 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTC Bulletin Board:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced…

Nephros Announces Strategic License and Supply Agreement with Medica S.p.A for Ultrafiltration Products

By nephros, In , On April 23, 2012

RIVER EDGE, NJ – April 23, 2012 - Nephros, Inc. (OTC Bulletin Board: NEPH), a medical device company developing and marketing filtration products for therapeutic applications, infection control, and advanced…

Nephros Reports Third Quarter 2012 Financial Results

By nephros, In , On November 08, 2012

RIVER EDGE, NJ, November 8, 2012 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTC Bulletin Board:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced…

Nephros Reports Second Quarter 2012 Financial Results

By nephros, In , On August 14, 2012

RIVER EDGE, NJ, August 14, 2012 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTC Bulletin Board:NEPH), a global medical device company developing and marketing filtration products for therapeutic applications, infection control, and…

Nephros Announces Expansion of U.S. Sales Team

By nephros, In , On July 24, 2012

RIVER EDGE, NJ, July 24, 2012 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTC Bulletin Board:NEPH), a global medical device company developing and marketing filtration products for therapeutic applications, infection control, and…

Nephros Reports First Quarter 2012 Financial Results

By nephros, In , On May 15, 2012

RIVER EDGE, NJ, May 15, 2012 /PR Newswire-FirstCall/ -- Nephros, Inc. (OTC Bulletin Board:NEPH), a global medical device company developing and marketing filtration products for therapeutic applications, infection control, and…

Nephros Appoints John C. Houghton as President and Chief Executive Officer

By nephros, In , On April 23, 2012

RIVER EDGE, NJ – April 23, 2012 - Nephros, Inc. (OTC Bulletin Board: NEPH), a medical device company developing and marketing filtration products for therapeutic applications, infection control, and water…

Nephros Hires Director of U.S. Sales

By nephros, In , On March 14, 2012

RIVER EDGE, NJ – March 14, 2012 - Nephros, Inc. (OTC Bulletin Board: NEPH), a medical device company developing and marketing filtration products for therapeutic applications, infection control, and water…

Nephros, Inc. Announces Date of its 2012 Annual Meeting of Stockholders

By nephros, In , On February 10, 2012

RIVER EDGE, NJ – February 10, 2012 - Nephros, Inc. (OTC Bulletin Board: NEPH), a medical device company developing and marketing filtration products for therapeutic applications, infection control, and water…

Nephros Receives €750,000 Payment from Bellco S.r.l.

By nephros, In , On January 17, 2012

RIVER EDGE, N.J., January 17, 2012 /PRNewswire/ -- Nephros, Inc. (OTC Bulletin Board:NEPH.OB - News), a medical device company developing and marketing filtration products for therapeutic applications, infection control, and…